Sort   by:  
 Page size 
UnknownSafety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.
Not available
S-EPMC5559878 | biostudies-literature
UnknownLithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial.
Not available
S-EPMC8600458 | biostudies-literature
UnknownCharacteristics and Outcomes of US Patients Hospitalized With COVID-19.
Not available
S-EPMC8891038 | biostudies-literature
ProteomicsData-independent acquisition mass spectrometry to quantify protein levels in FFPE tumor biopsies for molecular diagnostics
Mass spectrometry-based protein quantitation is currently used to measure therapeutically relevant protein biomarkers in CAP/CLIA setting to predict likely responses of known therapies. Selected reaction monitoring (SRM) is the method of choice due to its outstanding analytical performance. However,...
ORGANISM(S): Homo Sapiens 
2019-10-22 | PXD010934 | panorama
UnknownEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219 | biostudies-literature
GenomicsAcquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes

We performed genome-wide copy number analysis with paired normal and tumor DNA obtained from 86 adult patients with de novo AML using the Affymetrix Genome-Wide Human SNP array 6.0 containing 1.85 million features. Acquired copy number alterations (CNA) were confirmed using an independent, hig...

phs000201.v1.p1 | EGA
TranscriptomicsGene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Training Set, Liver)
Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predict...
ORGANISM(S): Homo sapiens 
2010-05-18 | E-GEOD-10140 | biostudies-arrayexpress
TranscriptomicsGene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Training Set, HCC)
Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predict...
ORGANISM(S): Homo sapiens 
2010-05-19 | E-GEOD-10141 | biostudies-arrayexpress
TranscriptomicsGene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Validation Set)
Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predict...
ORGANISM(S): Homo sapiens 
2010-05-19 | E-GEOD-10142 | biostudies-arrayexpress
TranscriptomicsGene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predict...
ORGANISM(S): Homo sapiens 
2010-05-20 | E-GEOD-10143 | biostudies-arrayexpress
Sort   by:  
 Page size